The rapid adoption of electric vehicle technology means that there is now a growing supply of ‘nearly new’ EV batteries. One ...
No officers faced criminal prosecution in any of the cases, but many resulted in civil lawsuits.
Olatec Therapeutics, Inc. ("Olatec"), developing one of the most clinically advanced specific oral NLRP3 inhibitors, dapansutrile, today announced that two patients have been randomized in a 12-month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results